Form 8-K - Current report:
SEC Accession No. 0001193125-25-235819
Filing Date
2025-10-09
Accepted
2025-10-09 16:05:27
Documents
10
Period of Report
2025-10-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K agen-20251008.htm   iXBRL 8-K 43260
  Complete submission text file 0001193125-25-235819.txt   145697

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT agen-20251008.xsd EX-101.SCH 23893
12 EXTRACTED XBRL INSTANCE DOCUMENT agen-20251008_htm.xml XML 4505
Mailing Address 3 FORBES ROAD LEXINGTON MA 02421
Business Address 3 FORBES ROAD LEXINGTON MA 02421 781-674-4410
AGENUS INC (Filer) CIK: 0001098972 (see all company filings)

EIN.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 251385148
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)